Clinton Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,527
Closed -$514K 392
2017
Q3
$514K Sell
5,527
-6,272
-53% -$583K 0.06% 286
2017
Q2
$1.07M Buy
+11,799
New +$1.07M 0.11% 271
2015
Q4
Sell
-3,126
Closed -$329K 757
2015
Q3
$329K Buy
+3,126
New +$329K 0.03% 531
2015
Q2
Sell
-1,891
Closed -$236K 582
2015
Q1
$236K Buy
+1,891
New +$236K 0.06% 403